Scroll to top

Opportunities to Include Health Economics in Substance Use Disorder Research

May 05, 2017

Bruce Schackman, PhD
Professor of Healthcare Policy and Research in Medicine, Weill Cornell Medical College
Director, CHERISH – The Center for Health Economics of Treatment Interventions
Substance Use Disorder, HCV, and HIV

About the Presentation: Dr. Schackman will describe types of health economics research relevant to substance use disorders and co-occurring conditions, how health economics can be incorporated into clinical trials of screening and treatment interventions, and how health economics researchers can collaborate with substance use disorder researchers conducting observational and implementation studies. Examples will be drawn from Dr. Schackman’s recent and ongoing collaborations related to opioid use disorder treatment and to screening and care for HIV and HCV in substance use treatment settings.

About the Presenter: Dr. Schackman is the Director of CHERISH, a multi-institutional Center of Excellence, funded by the National Institute on Drug Abuse (P30DA040500). CHERISH is a collaboration among researchers at Weill Cornell Medicine, Boston Medical Center, the University of Pennsylvania Leonard Davis Institute of Health Economics, and the University of Miami Miller School of Medicine. Dr. Schackman is the Saul P. Steinberg Distinguished Professor of Healthcare Policy & Research at Weill Cornell, where he conducts economic evaluations of the comparative effectiveness of health interventions alongside clinical trials and cohort studies, cost-effectiveness and comparative effectiveness simulation modeling studies, and implementation science studies—particularly relating to treatment of infectious diseases and substance use disorders. His current research includes economic evaluations of HIV and hepatitis C screening and treatment in substance use treatment settings, and economic evaluations of medication treatment of opioid use disorder.